中华放射肿瘤学杂志
中華放射腫瘤學雜誌
중화방사종류학잡지
CHINESE JOURNAL OF RADIATION ONCOLOGY
2010年
6期
528-531
,共4页
孙文洁%章真%胡伟刚%顾卫列%朱骥%李桂超%蔡钢%马学军
孫文潔%章真%鬍偉剛%顧衛列%硃驥%李桂超%蔡鋼%馬學軍
손문길%장진%호위강%고위렬%주기%리계초%채강%마학군
胃肿瘤/放射疗法%放射疗法,三维适形或调强%器官移动%自由呼吸
胃腫瘤/放射療法%放射療法,三維適形或調彊%器官移動%自由呼吸
위종류/방사요법%방사요법,삼유괄형혹조강%기관이동%자유호흡
Gastric neoplasms/radiotherapy%Radiotherapy,three-dimension conformal or intensity modulated%Organ motion%Free breathing
目的 比较整合呼吸移动因素后胃癌术后三维适形、调强放疗计划的靶区及部分正常组织剂量学差异,为临床计划设计时参考.方法 10例胃癌术后患者在平静自由呼吸状态下进行常规CT定位,设计三维适形(3DCRT)及调强放疗(IMRT)计划.根据患者呼吸时相情况生成概率分布函数(PDF),将所得PDF与三维静态剂量进行三维剂量卷积计算,得到自由呼吸状态下整合后的3DCRT与IMRT计划.比较呼吸移动因素整合后3DCRT与IMRT计划在靶区剂量分布和部分正常组织受量差异,如CTV接受100%处方剂量45 Gy的体积占靶体积百分比(V45)、肝脏接受40 Gy的体积(V40)和双侧肾脏V15、V18等.结果 整合呼吸移动因素后靶区剂量覆盖率和均匀性的IMRT计划优于3DCRT计划,其中V45为98%:87%(t=-3.35,P=0.010)、平均剂量为(46.81±0.75)Gy:(45.99±1.12)Gy(t=-0.31,P=0.030).正常组织中肝脏V40的IMRT计划明显低于3DCRT计划(12%:16%;t=3.75,P=0.010),左肾脏V15和V18的IMRT计划也明显低于3DCRT计划[34%∶50%(t=2.17,P=0.050)和27%∶46%(t=3.11,P=0.020)],右肾V15和V18的3DCRT计划略优于IMRT计划[15%∶21%(t=-2.42,P=0.040)和11%∶15%(t=-2.71,P=0.030)].结论 整合呼吸移动因素后,IMRT较3DCRT计划有更好靶区覆盖率和较低肝脏及左侧肾脏受量.
目的 比較整閤呼吸移動因素後胃癌術後三維適形、調彊放療計劃的靶區及部分正常組織劑量學差異,為臨床計劃設計時參攷.方法 10例胃癌術後患者在平靜自由呼吸狀態下進行常規CT定位,設計三維適形(3DCRT)及調彊放療(IMRT)計劃.根據患者呼吸時相情況生成概率分佈函數(PDF),將所得PDF與三維靜態劑量進行三維劑量捲積計算,得到自由呼吸狀態下整閤後的3DCRT與IMRT計劃.比較呼吸移動因素整閤後3DCRT與IMRT計劃在靶區劑量分佈和部分正常組織受量差異,如CTV接受100%處方劑量45 Gy的體積佔靶體積百分比(V45)、肝髒接受40 Gy的體積(V40)和雙側腎髒V15、V18等.結果 整閤呼吸移動因素後靶區劑量覆蓋率和均勻性的IMRT計劃優于3DCRT計劃,其中V45為98%:87%(t=-3.35,P=0.010)、平均劑量為(46.81±0.75)Gy:(45.99±1.12)Gy(t=-0.31,P=0.030).正常組織中肝髒V40的IMRT計劃明顯低于3DCRT計劃(12%:16%;t=3.75,P=0.010),左腎髒V15和V18的IMRT計劃也明顯低于3DCRT計劃[34%∶50%(t=2.17,P=0.050)和27%∶46%(t=3.11,P=0.020)],右腎V15和V18的3DCRT計劃略優于IMRT計劃[15%∶21%(t=-2.42,P=0.040)和11%∶15%(t=-2.71,P=0.030)].結論 整閤呼吸移動因素後,IMRT較3DCRT計劃有更好靶區覆蓋率和較低肝髒及左側腎髒受量.
목적 비교정합호흡이동인소후위암술후삼유괄형、조강방료계화적파구급부분정상조직제량학차이,위림상계화설계시삼고.방법 10례위암술후환자재평정자유호흡상태하진행상규CT정위,설계삼유괄형(3DCRT)급조강방료(IMRT)계화.근거환자호흡시상정황생성개솔분포함수(PDF),장소득PDF여삼유정태제량진행삼유제량권적계산,득도자유호흡상태하정합후적3DCRT여IMRT계화.비교호흡이동인소정합후3DCRT여IMRT계화재파구제량분포화부분정상조직수량차이,여CTV접수100%처방제량45 Gy적체적점파체적백분비(V45)、간장접수40 Gy적체적(V40)화쌍측신장V15、V18등.결과 정합호흡이동인소후파구제량복개솔화균균성적IMRT계화우우3DCRT계화,기중V45위98%:87%(t=-3.35,P=0.010)、평균제량위(46.81±0.75)Gy:(45.99±1.12)Gy(t=-0.31,P=0.030).정상조직중간장V40적IMRT계화명현저우3DCRT계화(12%:16%;t=3.75,P=0.010),좌신장V15화V18적IMRT계화야명현저우3DCRT계화[34%∶50%(t=2.17,P=0.050)화27%∶46%(t=3.11,P=0.020)],우신V15화V18적3DCRT계화략우우IMRT계화[15%∶21%(t=-2.42,P=0.040)화11%∶15%(t=-2.71,P=0.030)].결론 정합호흡이동인소후,IMRT교3DCRT계화유경호파구복개솔화교저간장급좌측신장수량.
Objective To compare the dose distribution of the target and normal tissues in gastric cancers between three-dimension conformal radiation therapy (3DCRT) and intensity modulated radiation therapy (IMRT) plan when respiratory motion factors integrated in the plan. Methods From January 2005to November 2006, 10 patients with post-operatively radiation of gastric cancer were enrolled in this study.Planning CT were acquired conventionally with free-breath mode and the static treatment plans of the 3DCRT and IMRT were designed respectively. Probability distribution functions (PDF) were generated and convoluted with the static dose distributions from 3DCRT and IMRT plans to obtain the integrated plans. The dose distributions of the target and normal tissues were compared between 3DCRT and IMRT integration treatment plans, such as V45 of clinical target volume, V4o of liver and V15, V18 of left and right kidney.Results In the respiratory integrated treatment planning, the target volume coverage and homogeneity with IMRT are superior to those with 3DCRT ( ( V45 98%∶ 87% (t = -3. 35 ,P =0. 010) ,mean dose 46. 81 Gy ±0. 75 Gy∶45.99 Gy ± 1.12 Gy (t = -0. 31 ,P=0. 020) ). The V40 of teh liver in IMRT are smaller than those in 3DCRT ( 12%∶ 16% ;t=3.75,P=0.010). For the left kidney, the V15 and V18 in IMRT are smaller than those in 3DCRT ( (34%∶ 50% (t = 2. 17 ,P = 0. 050) and 27%∶46% (t = 3. 11 ,P = 0. 020) ),but for the right kidney, V15 and V18 in 3DCRT are smaller than those in IMRT ( ( 15%∶ 21% (t = - 2. 42,P=0.040) and 11%∶15% (t= -2.71,P=0.030)). Conclusions When respiratory motion factor integrated in the treatment plan, IMRT showed advantage both in target coverage and normal tissue sparing in the high dose region of liver and left kidney.